Wall Street PR

Lisa Ray

Incyte Corporation (NASDAQ:INCY) stock trading up

Boston, MA 10/04/2013 (wallstreetpr)  –  Incyte Corporation (NASDAQ:INCY) has announced the results of a 28-day, PhaseII, placebo-controlled clinical-trial that was conducted on 50 patients suffering from

Incyte Corporation (NASDAQ:INCY) stock trading up

Boston, MA 10/04/2013 (wallstreetpr)  –  Incyte Corporation (NASDAQ:INCY) has announced the results of a 28-day, PhaseII, placebo-controlled clinical-trial that was conducted on 50 patients suffering from